APOE and AD concordance in twin pairs as predictors of AD in first- degree relatives

Neurology

Volumn 54, Issue 3, 2000, Pages 593-598

  Steffens, David C ^a   Plassman, B L ^a   Helms, M J ^a   Welsh Bohmer, K A ^a   Newman, T T ^a   Breitner, J C S ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

AD; Apolipoprotein E; Family; Twins

Indexed keywords

APOLIPOPROTEIN E;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; FAMILY HISTORY; FEMALE; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RELATIVE; TWIN CONCORDANCE;

EID: 0034620604     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.54.3.593     Document Type: Article

References (25)

1. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele E4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-1472.
2. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-923.
3. Karlinsky H, Berg JM, Lennox A, et al. Monozygotic twins concordant for late-onset probable Alzheimer disease with suspected Alzheimer disease in four sibs. Am J Med Genet 1992;44:591-597.
4. Rapoport SI, Pettigrew KD, Schapiro MB. Discordance and concordance of dementia of the Alzheimer type (DAT) in monozygotic twins indicate heritable and sporadic forms of Alzheimer's disease. Neurology 1991;41:1549-1553.
5. Breitner JCS, Welsh KA, Gau BA, et al. Alzheimer's disease in the National Academy of Sciences-National Research Council Registry of aging twin veterans. III. Detection of patients, longitudinal results, and observations on twin concordance. Arch Neurol 1995;52:763-771.
6. Brandt JM, Spencer M, Folstein M. The telephone interview for cognitive status. Neuropsychiatry Neuropsychol Behav Neurol 1988;1:111-117.
7. Welsh KA, Breitner JCS, Magruder-Habib KM. Detection of dementia in the elderly using telephone screening of cognitive status. Neuropsychiatry Neuropsychol Behav Neurol 1993;6: 103-110.
8. Silverman JM, Breitner JCS, Mohs RC, Davis KL. Reliability of the family history method in genetic studies of Alzheimer's disease and related dementias. Am J Psychiatry 1986;143: 1279-1282.
9. Gallo JJ, Breitner JCS. Alzheimer's disease in the N.A.S.-N.R.C. Registry of aging twin veterans. IV. Performance characteristics of a two-stage telephone screening procedure for Alzheimer's dementia. Psychol Med 1995;25:1211-1219.
10. Ellis RJ, Jan K, Kawas C, et al. Diagnostic validity of the Dementia Questionnaire for Alzheimer disease. Arch Neurol 1998;55:360-365.
11. Steffens DC, Welsh KA, Burke J, et al. Diagnosis of Alzheimer's disease in epidemiologic studies by staged review of clinical data. Neuropsychiatry Neuropsychol Behav Neurol 1996;9:107-113.
12. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
13. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-486.
14. Torgersen S. The determination of twin zygosity by means of a mailed questionnaire. Acta Genet Med Gemellol (Roma) 1979; 28:225-236.
15. Cederlof R, Friberg L, Jonsson E, Kaij L. Studies on similarity diagnosis in twins with the aid of mailed questionnaires. Acta Genet (Basel) 1961;11:338-362.
16. Wenham PR, Price WH, Blundell G. Apolipoprotein E genotyping by one-stage PCR. Lancet 1991;337:1158-1159.
17. Hixson JE, Vernier DR. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hha I. J Lipid Res 1990;31:545-548.
18. Payami H, Grimslid H, Oken B, et al. A prospective study of cognitive health in the elderly (Oregon Brain Aging Study): effects of family history and apolipoprotein E genotype. Am J Hum Genet 1997;60:948-956.
19. Martinez M, Campion D, Brice A, et al. Apolipoprotein E epsilon 4 allele and familial aggregation of Alzheimer disease. Arch Neurol 1998;55:810-816.
20. Duara R, Barker WW, Lopez-Alberola R, et al. Alzheimer's disease: interaction of apolipoprotein E genotype, family history of dementia, gender, education, ethnicity, and age of onset. Neurology 1996;46:1575-1579.
21. Reed T, Carmelli D, Swan GE, et al. Lower cognitive performance in normal older adult male twins carrying the apolipoprotein E epsilon 4 allele. Arch Neurol 1994;1:1189-1192.
22. Small GW, Mazziotta JC, Collins MT, et al. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer's disease. JAMA 1995;273:942-947.
23. Mayeux R, Saunders AM, Shea S, et al. Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease. N Engl J Med 1998; 338:506-511.
24. Pericak-Vance MA, Bass MP, Yamaoka LH, et al. Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12. JAMA 1997;278: 1237-1241.
25. Blacker D, Wilcox MA, Laird NM, et al. Alpha-2 macroglobulin is genetically associated with Alzheimer disease. Nat Genet 1998;19:357-360.